MedTrace Logo

Comparison of Electroacupuncture to Mirabegron for Treatment of Overactive Bladder

NCT03087578 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-05-06

No results posted yet for this study

Summary

This study compares electroacupuncture to mirabegron for treatment of overactive bladder (OAB) symptoms in women who have failed treatment with anticholingeric therapy.

Conditions

Interventions

OTHER

electroacupncture

Patients will receive electroacupuncture treatment for 30 minutes per weekly session for 6 weeks.

DRUG

Mirabegron 50 MG [Myrbetriq]

Patients will receive 50 mg of mirabegron daily for 6 weeks.

Sponsors & Collaborators

  • University Hospitals Cleveland Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2018-07-01
Completion
2018-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03087578 on ClinicalTrials.gov